{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:35:18Z","timestamp":1793306118226,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08474-2","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T08:02:44Z","timestamp":1729497764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multicenter, randomized, adaptive allocation clinical trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Milena","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey","family":"Staugaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Niedernhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Tchkonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Hines","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Ventz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Koopmeiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6358-4670","authenticated-orcid":false,"given":"Michael A.","family":"Puskarich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The STOP-Sepsis Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimaje","family":"Akpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Ingraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Kesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aahd","family":"Kubbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Pendleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Reilkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Skolasinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"8","key":"8474_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"8","key":"8474_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA"},{"issue":"8","key":"8474_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775\u201387.","journal-title":"JAMA"},{"issue":"10219","key":"8474_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"3","key":"8474_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/healthcare6030090","volume":"6","author":"J Hajj","year":"2018","unstructured":"Hajj J, Blaine N, Salavaci J, Jacoby D. The, \u201cCentrality of Sepsis\u201d: a review on incidence, mortality, and cost of care. Healthcare (Basel). 2018;6(3):90.","journal-title":"Healthcare (Basel)"},{"issue":"9","key":"8474_CR6","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"8474_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"8474_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8474_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.14336\/AD.2020.0627","volume":"12","author":"W He","year":"2021","unstructured":"He W, Xiao K, Fang M, Xie L. Immune cell number, phenotype, and function in the elderly with sepsis. Aging Dis. 2021;12(1):277\u201396.","journal-title":"Aging Dis"},{"key":"8474_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcrc.2020.12.015","volume":"62","author":"G Wardi","year":"2021","unstructured":"Wardi G, Tainter CR, Ramnath VR, Brennan JJ, Tolia V, Castillo EM, et al. Age-related incidence and outcomes of sepsis in California, 2008\u20132015. J Crit Care. 2021;62:212\u20137.","journal-title":"J Crit Care"},{"issue":"1","key":"8474_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.CCM.0000194535.82812.BA","volume":"34","author":"GS Martin","year":"2006","unstructured":"Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34(1):15\u201321.","journal-title":"Crit Care Med"},{"issue":"2","key":"8474_CR12","first-page":"126","volume":"5","author":"ME Starr","year":"2014","unstructured":"Starr ME, Saito H. Sepsis in old age: review of human and animal studies. Aging Dis. 2014;5(2):126\u201336.","journal-title":"Aging Dis"},{"issue":"9","key":"8474_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/jgs.16435","volume":"68","author":"RT Mankowski","year":"2020","unstructured":"Mankowski RT, Anton SD, Ghita GL, Brumback B, Cox MC, Mohr AM, et al. Older sepsis survivors suffer persistent disability burden and poor long-term survival. J Am Geriatr Soc. 2020;68(9):1962\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"8474_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966\u201372.","journal-title":"J Clin Invest"},{"key":"8474_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T. Cellular senescence: a translational perspective. EBioMedicine. 2017;21:21\u20138.","journal-title":"EBioMedicine"},{"issue":"10","key":"8474_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/bmt.2015.143","volume":"50","author":"A Rosko","year":"2015","unstructured":"Rosko A, Hofmeister C, Benson D, Efebera Y, Huang Y, Gillahan J, et al. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transplant. 2015;50(10):1379\u201381.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"8474_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1474-9726.2009.00489.x","volume":"8","author":"Y Liu","year":"2009","unstructured":"Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8(4):439\u201348.","journal-title":"Aging Cell"},{"key":"8474_CR18","first-page":"20","volume":"4","author":"S Martin","year":"2017","unstructured":"Martin S, Perez A, Aldecoa C. Sepsis and Immunosenescence in the elderly patient: a review. Front Med (Lausanne). 2017;4:20.","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 7","key":"8474_CR19","doi-asserted-by":"publisher","first-page":"S504","DOI":"10.1086\/432007","volume":"41","author":"SM Opal","year":"2005","unstructured":"Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504\u201312.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8474_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/gerona\/glab028","volume":"76","author":"S Romashkan","year":"2021","unstructured":"Romashkan S, Chang H, Hadley EC. National Institute on aging workshop: repurposing drugs or dietary supplements for their senolytic or senomorphic effects: considerations for clinical trials. J Gerontol A Biol Sci Med Sci. 2021;76(6):1144\u201352.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"8474_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s10753-014-9883-4","volume":"37","author":"H Yoo","year":"2014","unstructured":"Yoo H, Ku SK, Han MS, Kim KM, Bae JS. Anti-septic effects of fisetin in vitro and in vivo. Inflammation. 2014;37(5):1560\u201374.","journal-title":"Inflammation"},{"issue":"1","key":"8474_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10753-015-0233-y","volume":"39","author":"G Feng","year":"2016","unstructured":"Feng G, Jiang ZY, Sun B, Fu J, Li TZ. Fisetin alleviates lipopolysaccharide-induced acute lung injury via TLR4-ediated NF-kappaB Signaling Pathway in Rats. Inflammation. 2016;39(1):148\u201357.","journal-title":"Inflammation"},{"key":"8474_CR23","doi-asserted-by":"publisher","first-page":"109772","DOI":"10.1016\/j.biopha.2019.109772","volume":"122","author":"Q Ren","year":"2020","unstructured":"Ren Q, Guo F, Tao S, Huang R, Ma L, Fu P. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-kappaB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020;122:109772.","journal-title":"Biomed Pharmacother"},{"key":"8474_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18\u201328.","journal-title":"EBioMedicine"},{"issue":"11","key":"8474_CR25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.bcp.2011.07.097","volume":"82","author":"YS Touil","year":"2011","unstructured":"Touil YS, Auzeil N, Boulinguez F, Saighi H, Regazzetti A, Scherman D, et al. Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite. Biochem Pharmacol. 2011;82(11):1731\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"8474_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, Belletti A, Khanna AK. An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care. 2023;27(1):29.","journal-title":"Crit Care"},{"issue":"14","key":"8474_CR27","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754\u20138.","journal-title":"JAMA"},{"issue":"5","key":"8474_CR28","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","volume":"37","author":"AE Jones","year":"2009","unstructured":"Jones AE, Trzeciak S, Kline JA. The Sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649\u201354.","journal-title":"Crit Care Med"},{"issue":"1","key":"8474_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","volume":"21","author":"HJ de Grooth","year":"2017","unstructured":"de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;21(1):38.","journal-title":"Crit Care"},{"issue":"11","key":"8474_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171\u20138.","journal-title":"J Clin Epidemiol."},{"issue":"6","key":"8474_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"8474_CR32","unstructured":"Plummer M. rjags: Bayesian graphical models using MCMC. 2013. Available from: \nhttps:\/\/cran.r-project.org\/package=rjags."},{"key":"8474_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"8474_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical Analysis with Missing Data","author":"R Little","year":"2002","unstructured":"Little R, Rubin D. Statistical Analysis with Missing Data. 2nd ed. Hoboken: John Wiley & Sons, Inc; 2002.","edition":"2"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08474-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T08:10:31Z","timestamp":1729498231000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08474-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8474"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08474-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this trial was centrally approved by the Advarra IRB (Protocol number Pro00070555) and subsequently approved by individual site IRBs (University of Minnesota\u2014SITE00001869 which covers four of the participating hospitals; Hennepin County Medical Center\u2014IRB-FY2023-660 which covers the fifth). Informed consent documented either in writing or by e-consent per local institutional protocols will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable. We do not anticipate publication of any details, images, or videos relating to any individual subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"MS declares that she has no competing interests.DAW declares that he has no competing interests.BED declares that he has no competing interestsAS declares that she has no competing interests.ELS declares that she has no competing interests.LJN declares that she has no competing interests.TE declares that she has no competing interests.CHS declares that he has no competing interests.JSK declares that he has no competing interests.MAP declares he has no competing interests.SV is funded in part by a Medtronic faculty fellowship and an MSI data science seed grant; he declares that he has no other competing interests.JLK, TT, and Mayo Clinic, where JLK is an emeritus professor, hold patents related to senolytic agents.JLK holds no shares in companies developing senolytics. TT holds shares of Unity Biotechnology.Participation of JLK in this study is in compliance with Mayo Clinic\u2019s conflict of interest policies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"698"}}